🇺🇸 FDA
Patent

US 9402881

Tissue regeneration and wound treatment methods with platelet derived compositions

granted A61KA61K35/19A61K38/1808

Quick answer

US patent 9402881 (Tissue regeneration and wound treatment methods with platelet derived compositions) held by The Regents of the University of Colorado, a Body Corporate expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K35/19, A61K38/1808, A61K38/1841, A61K38/1858